Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS ‐2 study

Allergy, EarlyView.

Source: Allergy - June 18, 2018 Category: Allergy & Immunology Authors: M. A. Riedl , E. Ayg ören‐Pürsün , J. Baker , H. Farkas , J. Anderson , J. A. Bernstein , L. Bouillet , P. Busse , M. Manning , M. Magerl , M. Gompels , A. P. Huissoon , H. Longhurst , W. Lumry , B. Ritchie , R. Sha Source Type: research